Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis
NCT ID: NCT02266121
Last Updated: 2023-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
100 participants
INTERVENTIONAL
2014-10-31
2023-05-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Electrical Stimulation in Multiple Sclerosis
NCT06966128
A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)
NCT03499314
Non-invasive Transcranial Electrical Stimulation in MS
NCT04466228
Effect of Repeated tDCS Sessions on Cognitive Improvement in Patients With Disorders of Consciousness
NCT02394691
The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis
NCT01280539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Baseline and follow-up outcomes about cognitive aptitudes, motor tasks and fatigue will be collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
real tDCS
Patients will receive non-invasive and painless brain stimulation over the rain areas involved in cognitive aptitudes.
tDCS will be applied during 20 minutes while patients will perform attentional, working memory and executive tasks
tDCS
Device: transcranial direct current stimulation tDCS tdcs (ELDITH, Neuroconn, Ilmenau, Germany)
Sham tDCS
this will be exactly as for "real tDCS" unless that the tDCS will be rapidly turned off, unbeknown from patients-therapist-examinator (double-blind trial)
tDCS
Device: transcranial direct current stimulation tDCS tdcs (ELDITH, Neuroconn, Ilmenau, Germany)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS
Device: transcranial direct current stimulation tDCS tdcs (ELDITH, Neuroconn, Ilmenau, Germany)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cognitive deficits
* Motor deficits
Exclusion Criteria
* major psychiatric conditions or major depression
* coexisting instable medical condition
* substance or alcohol abuse
* regular intake of drug that strongly modulate brain excitability
* major sequels from MS preventing participation in the study
* pregnancy
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université Catholique de Louvain
OTHER
Teva Pharmaceuticals USA
INDUSTRY
University Hospital of Mont-Godinne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr Yves Vandermeeren, MD, PhD
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology, CHU Dinant Godinne UcL Namur
Yvoir, Namur, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B039201421534
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.